NAN Fung Trinity (hk) portfolio
Type not verifiedPortfolio as of Jun 30, 2026 (Q2 2026) · filed with the SEC on Jul 24, 2026 · data updated on Nov 5, 2026 · Q2 2026 13F (filing) ↗ · all its 13F filings ↗
A 13F shows the portfolio at quarter-end and is filed up to 45 days later: these are not real-time positions and they may have changed.
NAN Fung Trinity (hk) reported a $1.0 bn portfolio of 55 positions to the SEC as of the end of Q2 2026. Its largest positions are AMD, AMCR, PPG. During the quarter it opened Iren and Vor Biopharma and exited Ishares and Pinterest.
Sections with a free account
What changed this quarter
35 positions with a change (5 new, 13 added to, 6 trimmed, 11 sold); also, 2 exited through an acquisition or merger, 1 entered through a spin-off. 12 are listed here: those of 0.5 points of the portfolio or more (up to 12).
- Ishares−3.5 ppof portfolioSold out3.9% → —
- GE Healthcare Technologies+203%more sharesIncreased1.6% → 4.0%
- Advanced Micro Devices−28%fewer sharesReduced3.6% → 6.7%
- UnitedHealth Group−34%fewer sharesReduced3.1% → 2.8%
- Iren+1.3 ppof portfolioNew— → 1.3%
- Meta Platforms+146%more sharesIncreased1.0% → 2.1%
- Pinterest−1.2 ppof portfolioSold out1.3% → —
- Vor Biopharma+1.2 ppof portfolioNew— → 1.2%
- Target−1.2 ppof portfolioSold out1.3% → —
- Flex+1.2 ppof portfolioNew— → 1.2%
- CRH public+1.1 ppof portfolioNew— → 1.1%
- Microchip Technology−1.1 ppof portfolioSold out1.2% → —
The figure on the right: for positions added to or trimmed, the change in the number of shares (%); for new and sold ones, the points of the portfolio moved (pp). Below, the portfolio weight before → after. Traded weight: what it bought or sold, excluding price effects.
Top holdings
- Advanced Micro DevicesAMD6.7%
- AmcorAMCR5.1%
- PPG IndustriesPPG4.8%
- GE Healthcare TechnologiesGEHC4.0%
- NVIDIANVDA3.6%
- Home DepotHD3.5%
- KTKT3.3%
- iShares Msci Indonesia ETFEIDO3.3%
- iShares MBS ETFMBB3.3%
- Owens CorningOC2.9%
- UnitedHealth GroupUNH2.8%
- Air Products and ChemicalsAPD2.8%
- iShares Core S&P Midcap ETFIJH2.7%
- America Movil SAB De Cv/AMX2.7%
- Mirum PharmaceuticalsMIRM2.7%
“Since”: first quarter of the current run, unbroken until today. In the details, prices are the quarter-end prices of the quarters in which it added shares, per the 13F. The manager may have bought at any price within each quarter; the SEC only publishes the value at quarter end.
Portfolio by sector
- ● Health Care 34%
- ● Materials 15%
- ● Information Technology 13%
- ● No sector 12%
- ● Communication Services 10%
- ● Consumer Discretionary 7%
- ● Industrials 5%
- ● Real Estate 4%
How its portfolio changed (8 quarters)
Q2 2026: 55
Q2 2026: 41%
Q2 2026: 14.9%
Traded turnover: the weight it bought plus the weight it sold in the quarter, divided by two, excluding price moves. The plain “turnover” in the header does include that effect. With a free account: the full history and sectors over time.
Stakes above 5% (13D/13G)
Companies where this filer reported holding 5% or more of the shares. It is the figure from its latest filing on each one; history since December 2024.
How we classify it
Type not verified: we have not assigned a type because we found no document that is enough to tell. Most 13F filers are in this situation: we only review in depth those that meet the portfolio criteria.
Not counted as a concentrated manager: its top 10 positions are under 45%. Its portfolio is shown all the same, but it is left out of manager counts, the consensus and the ranking. How this is decided
Managers of a similar size
A 13F portfolio value between a third and three times this one, whatever the type of filer. It is not a comparison of what they hold.
- Gladstone Capital Management LLPInvestment firm · $1.0 bn
- Morguard Lincluden Global Investments$1.0 bn
- MAR Vista Investment PartnersInvestment firm · $1.0 bn
- Fort Baker Capital ManagementInvestment firm · $1.0 bn
- Provident Investment Management$999M
- Apis Capital AdvisorsInvestment firm · $1.0 bn